sj-docx-1-tam-10.1177_17588359211035983 – Supplemental material for Real-world efficacy and safety of nab-paclitaxel plus gemcitabine-cisplatin in patients with advanced biliary tract cancers: a multicenter retrospective analysis

sj-docx-1-ict-10.1177_15347354211038008 – Supplemental material for Pharmacological Interventions for the Management of Cancer-Related Fatigue Among Cancer Survivors: Systematic Review and Meta-Analysis

Xuemei Sun (811050)
Yancong Chen (4531312)
William KW Cheung (7438010)
Irene XY Wu (7438001)
Fang Xiao (173356)
Vincent CH Chung (7063412)

August 2021

Supplemental material, sj-docx-1-ict-10.1177_15347354211038008 for Pharmacological Interventions for...

sj-docx-3-tam-10.1177_17588359231225038 – Supplemental material for Analysis of circulating tumor DNA identifies distinct therapeutic response to intraperitoneal and intravenous paclitaxel plus S-1 in gastric cancer patients with peritoneal metastasis

Hong Yuan (104486)
Fei Xu (368913)
Shengzhou Wang (9196707)
Di Liu (30843)
Huan Zhang (220065)
Jun Zhang (48506)
Min Shi (141075)
Chao Yan (150844)
Zhenggang Zhu (297842)

January 2024

Supplemental material, sj-docx-3-tam-10.1177_17588359231225038 for Analysis of circulating tumor DNA...

sj-docx-1-opp-10.1177_10781552221126174 - Supplemental material for Economic burden in patients with anaplastic lymphoma kinase (ALK)-positive non-small cell lung cancer (NSCLC), with or without brain metastases, receiving first-line ALK inhibitors

Yanyu Wu (6634754)
Kaili Ren (3845098)
Yin Wan (4164121)
Huamao M Lin (12614506)

September 2022

Supplemental material, sj-docx-1-opp-10.1177_10781552221126174 for Economic burden in patients with ...

Real-world efficacy and safety of nab-paclitaxel plus gemcitabine-cisplatin in patients with advanced biliary tract cancers: a multicenter retrospective analysis

Jaekyung Cheon
Choong-kun Lee
Yun Beom Sang
Hye Jin Choi
Min Hwan Kim
Jun Ho Ji
Kwang Hyun Ko
Chang-Il Kwon
Dae Jung Kim
Sung Hoon Choi
Chan Kim
Beodeul Kang
Hong Jae Chon

August 2021

Background: A recent phase II trial reported prolonged survival in patients with advanced biliary tr...

sj-docx-1-tam-10.1177_17588359231221336 – Supplemental material for Combined use of Anlotinib with chemotherapy in patients with advanced ovarian cancer: a real-world cohort study and meta-analysis

XinYi Hong (17746125)
ShanHu Qiu (17746128)
Bo Ding (210928)
Hao Xu (6530)
Yang Shen (66591)

January 2024

Supplemental material, sj-docx-1-tam-10.1177_17588359231221336 for Combined use of Anlotinib with ch...

Real-world efficacy and safety of nab-paclitaxel plus gemcitabine-cisplatin in patients with advanced biliary tract cancers: a multicenter retrospective analysis

김민환
이충근
최혜진

August 2021

Background: A recent phase II trial reported prolonged survival in patients with advanced biliary tr...

sj-docx-1-tag-10.1177_17562848221137758 – Supplemental material for Adjuvant chemotherapy improves survival in high-risk stage II colon cancer: a retrospective cohort study

Lin-Lin Liu (127878)
Zuo-Lin Xiang (7048145)

November 2022

Supplemental material, sj-docx-1-tag-10.1177_17562848221137758 for Adjuvant chemotherapy improves su...

sj-docx-1-tam-10.1177_17588359231220516 – Supplemental material for TQB2450 in patients with advanced malignant tumors: results from a phase I dose-escalation and expansion study

Junli Xue (8716245)
Liqiong Xue (503274)
Wenbo Tang (110161)
Xiaoxiao Ge (1398166)
Wei Zhao (14321)
Qun Li (222962)
Wei Peng (432211)
Congqi Dai (15289253)
Ye Guo (224500)
Jin Li (119007)

January 2024

Supplemental material, sj-docx-1-tam-10.1177_17588359231220516 for TQB2450 in patients with advanced...

sj-docx-1-tam-10.1177_17588359221148541 – Supplemental material for Atezolizumab plus bevacizumab in patients with child–Pugh B advanced hepatocellular carcinoma

Jaekyung Cheon (6735305)
Hyeyeong Kim (12415075)
Han Sang Kim (5474396)
Chang Gon Kim (11928258)
Ilhwan Kim (5235122)
Beodeul Kang (3585176)
Chan Kim (467480)
Sanghoon Jung (13107311)
Yeonjung Ha (14426256)
Hong Jae Chon (8907980)

January 2023

Supplemental material, sj-docx-1-tam-10.1177_17588359221148541 for Atezolizumab plus bevacizumab in ...

sj-docx-6-tam-10.1177_17588359221137429 – Supplemental material for Adjunctive PD-1 inhibitor versus standard chemotherapy in recurrent or metastatic nasopharyngeal carcinoma: a systematic review and meta-analysis

Edgar Theodore Polintan (14121865)
Stephanie Krystel Canicula (14121868)
Jesus Alfonso Catahay (12158921)
Kevin Bryan Lo (9459578)
Miguel Villalona-Calero (3767593)
Herbert Ho-fung Loong (12463611)

November 2022

Supplemental material, sj-docx-6-tam-10.1177_17588359221137429 for Adjunctive PD-1 inhibitor versus ...

sj-docx-1-tam-10.1177_17588359221122733 – Supplemental material for First-line nivolumab plus ipilimumab or chemotherapy versus chemotherapy alone for advanced esophageal cancer: a cost-effectiveness analysis

Xueqiong Cao (13201374)
Hongfu Cai (9732137)
Na Li (6550)
Bin Zheng (45359)
Zhiwei Zheng (736521)
Maobai Liu (9732134)

September 2022

Supplemental material, sj-docx-1-tam-10.1177_17588359221122733 for First-line nivolumab plus ipilimu...

sj-docx-7-tam-10.1177_17588359221137429 – Supplemental material for Adjunctive PD-1 inhibitor versus standard chemotherapy in recurrent or metastatic nasopharyngeal carcinoma: a systematic review and meta-analysis

Edgar Theodore Polintan (14121865)
Stephanie Krystel Canicula (14121868)
Jesus Alfonso Catahay (12158921)
Kevin Bryan Lo (9459578)
Miguel Villalona-Calero (3767593)
Herbert Ho-fung Loong (12463611)

November 2022

Supplemental material, sj-docx-7-tam-10.1177_17588359221137429 for Adjunctive PD-1 inhibitor versus ...

sj-docx-1-tam-10.1177_17588359221128356 – Supplemental material for Efficacy of neoadjuvant docetaxel + cisplatin chemo-hormonal therapy versus docetaxel chemo-hormonal therapy in patients with locally advanced prostate cancer with germline DNA damage repair gene alterations

Chenfei Chi (6039347)
Jiazhou Liu (10643840)
Liancheng Fan (5641550)
Yinjie Zhu (736022)
Yanqing Wang (250075)
Jianjun Sha (550443)
Yiran Huang (1450759)
Baijun Dong (329955)
Jiahua Pan (550442)
Wei Xue (219900)

September 2022

Supplemental material, sj-docx-1-tam-10.1177_17588359221128356 for Efficacy of neoadjuvant docetaxel...

sj-docx-1-tam-10.1177_17588359231204856 – Supplemental material for Eribulin combined with antiangiogenic agents in women with HER2-negative metastatic breast cancer: a retrospective multicenter study

Mingxia Jiang (6258284)
Bin Shao (460997)
Donggui Wan (9998840)
Jiaxuan Liu (5185280)
Maiyue He (17143666)
Yue Chai (7879145)
Die Sang (17143669)
Jiayu Wang (336277)
Fei Ma (113764)
Ying Fan (187798)
Peng Yuan (150866)
Binghe Xu (398866)
Qiao Li (571252)

October 2023

Supplemental material, sj-docx-1-tam-10.1177_17588359231204856 for Eribulin combined with antiangiog...

Supplementary_Table_1 – Supplemental material for Real-world comparative effectiveness of nab-paclitaxel plus gemcitabine versus FOLFIRINOX in advanced pancreatic cancer: a systematic review

Elena Gabriela Chiorean (6734783)
Winston Y. Cheung (6734786)
Guido Giordano (3439904)
George Kim (3385205)
Salah-Eddin Al-Batran (11098)

May 2019

Supplemental material, Supplementary_Table_1 for Real-world comparative effectiveness of nab-paclita...

sj-docx-1-ict-10.1177_15347354211038008 – Supplemental material for Pharmacological Interventions for the Management of Cancer-Related Fatigue Among Cancer Survivors: Systematic Review and Meta-Analysis

Xuemei Sun (811050)
Yancong Chen (4531312)
William KW Cheung (7438010)
Irene XY Wu (7438001)
Fang Xiao (173356)
Vincent CH Chung (7063412)

August 2021

Supplemental material, sj-docx-1-ict-10.1177_15347354211038008 for Pharmacological Interventions for...

sj-docx-3-tam-10.1177_17588359231225038 – Supplemental material for Analysis of circulating tumor DNA identifies distinct therapeutic response to intraperitoneal and intravenous paclitaxel plus S-1 in gastric cancer patients with peritoneal metastasis

Hong Yuan (104486)
Fei Xu (368913)
Shengzhou Wang (9196707)
Di Liu (30843)
Huan Zhang (220065)
Jun Zhang (48506)
Min Shi (141075)
Chao Yan (150844)
Zhenggang Zhu (297842)

January 2024

Supplemental material, sj-docx-3-tam-10.1177_17588359231225038 for Analysis of circulating tumor DNA...

sj-docx-1-opp-10.1177_10781552221126174 - Supplemental material for Economic burden in patients with anaplastic lymphoma kinase (ALK)-positive non-small cell lung cancer (NSCLC), with or without brain metastases, receiving first-line ALK inhibitors

Yanyu Wu (6634754)
Kaili Ren (3845098)
Yin Wan (4164121)
Huamao M Lin (12614506)

September 2022

Supplemental material, sj-docx-1-opp-10.1177_10781552221126174 for Economic burden in patients with ...

Real-world efficacy and safety of nab-paclitaxel plus gemcitabine-cisplatin in patients with advanced biliary tract cancers: a multicenter retrospective analysis

Jaekyung Cheon
Choong-kun Lee
Yun Beom Sang
Hye Jin Choi
Min Hwan Kim
Jun Ho Ji
Kwang Hyun Ko
Chang-Il Kwon
Dae Jung Kim
Sung Hoon Choi
Chan Kim
Beodeul Kang
Hong Jae Chon

August 2021

Background: A recent phase II trial reported prolonged survival in patients with advanced biliary tr...

sj-docx-1-tam-10.1177_17588359231221336 – Supplemental material for Combined use of Anlotinib with chemotherapy in patients with advanced ovarian cancer: a real-world cohort study and meta-analysis

XinYi Hong (17746125)
ShanHu Qiu (17746128)
Bo Ding (210928)
Hao Xu (6530)
Yang Shen (66591)

January 2024

Supplemental material, sj-docx-1-tam-10.1177_17588359231221336 for Combined use of Anlotinib with ch...

Real-world efficacy and safety of nab-paclitaxel plus gemcitabine-cisplatin in patients with advanced biliary tract cancers: a multicenter retrospective analysis

김민환
이충근
최혜진

August 2021

Background: A recent phase II trial reported prolonged survival in patients with advanced biliary tr...

sj-docx-1-tag-10.1177_17562848221137758 – Supplemental material for Adjuvant chemotherapy improves survival in high-risk stage II colon cancer: a retrospective cohort study

Lin-Lin Liu (127878)
Zuo-Lin Xiang (7048145)

November 2022

Supplemental material, sj-docx-1-tag-10.1177_17562848221137758 for Adjuvant chemotherapy improves su...

sj-docx-1-tam-10.1177_17588359231220516 – Supplemental material for TQB2450 in patients with advanced malignant tumors: results from a phase I dose-escalation and expansion study

Junli Xue (8716245)
Liqiong Xue (503274)
Wenbo Tang (110161)
Xiaoxiao Ge (1398166)
Wei Zhao (14321)
Qun Li (222962)
Wei Peng (432211)
Congqi Dai (15289253)
Ye Guo (224500)
Jin Li (119007)

January 2024

Supplemental material, sj-docx-1-tam-10.1177_17588359231220516 for TQB2450 in patients with advanced...

sj-docx-1-tam-10.1177_17588359221148541 – Supplemental material for Atezolizumab plus bevacizumab in patients with child–Pugh B advanced hepatocellular carcinoma

Jaekyung Cheon (6735305)
Hyeyeong Kim (12415075)
Han Sang Kim (5474396)
Chang Gon Kim (11928258)
Ilhwan Kim (5235122)
Beodeul Kang (3585176)
Chan Kim (467480)
Sanghoon Jung (13107311)
Yeonjung Ha (14426256)
Hong Jae Chon (8907980)

January 2023

Supplemental material, sj-docx-1-tam-10.1177_17588359221148541 for Atezolizumab plus bevacizumab in ...

sj-docx-6-tam-10.1177_17588359221137429 – Supplemental material for Adjunctive PD-1 inhibitor versus standard chemotherapy in recurrent or metastatic nasopharyngeal carcinoma: a systematic review and meta-analysis

Edgar Theodore Polintan (14121865)
Stephanie Krystel Canicula (14121868)
Jesus Alfonso Catahay (12158921)
Kevin Bryan Lo (9459578)
Miguel Villalona-Calero (3767593)
Herbert Ho-fung Loong (12463611)

November 2022

Supplemental material, sj-docx-6-tam-10.1177_17588359221137429 for Adjunctive PD-1 inhibitor versus ...

sj-docx-1-tam-10.1177_17588359221122733 – Supplemental material for First-line nivolumab plus ipilimumab or chemotherapy versus chemotherapy alone for advanced esophageal cancer: a cost-effectiveness analysis

Xueqiong Cao (13201374)
Hongfu Cai (9732137)
Na Li (6550)
Bin Zheng (45359)
Zhiwei Zheng (736521)
Maobai Liu (9732134)

September 2022

Supplemental material, sj-docx-1-tam-10.1177_17588359221122733 for First-line nivolumab plus ipilimu...

sj-docx-7-tam-10.1177_17588359221137429 – Supplemental material for Adjunctive PD-1 inhibitor versus standard chemotherapy in recurrent or metastatic nasopharyngeal carcinoma: a systematic review and meta-analysis

Edgar Theodore Polintan (14121865)
Stephanie Krystel Canicula (14121868)
Jesus Alfonso Catahay (12158921)
Kevin Bryan Lo (9459578)
Miguel Villalona-Calero (3767593)
Herbert Ho-fung Loong (12463611)

November 2022

Supplemental material, sj-docx-7-tam-10.1177_17588359221137429 for Adjunctive PD-1 inhibitor versus ...

sj-docx-1-tam-10.1177_17588359221128356 – Supplemental material for Efficacy of neoadjuvant docetaxel + cisplatin chemo-hormonal therapy versus docetaxel chemo-hormonal therapy in patients with locally advanced prostate cancer with germline DNA damage repair gene alterations

Chenfei Chi (6039347)
Jiazhou Liu (10643840)
Liancheng Fan (5641550)
Yinjie Zhu (736022)
Yanqing Wang (250075)
Jianjun Sha (550443)
Yiran Huang (1450759)
Baijun Dong (329955)
Jiahua Pan (550442)
Wei Xue (219900)

September 2022

Supplemental material, sj-docx-1-tam-10.1177_17588359221128356 for Efficacy of neoadjuvant docetaxel...

sj-docx-1-tam-10.1177_17588359231204856 – Supplemental material for Eribulin combined with antiangiogenic agents in women with HER2-negative metastatic breast cancer: a retrospective multicenter study

Mingxia Jiang (6258284)
Bin Shao (460997)
Donggui Wan (9998840)
Jiaxuan Liu (5185280)
Maiyue He (17143666)
Yue Chai (7879145)
Die Sang (17143669)
Jiayu Wang (336277)
Fei Ma (113764)
Ying Fan (187798)
Peng Yuan (150866)
Binghe Xu (398866)
Qiao Li (571252)

October 2023

Supplemental material, sj-docx-1-tam-10.1177_17588359231204856 for Eribulin combined with antiangiog...

Supplementary_Table_1 – Supplemental material for Real-world comparative effectiveness of nab-paclitaxel plus gemcitabine versus FOLFIRINOX in advanced pancreatic cancer: a systematic review

Elena Gabriela Chiorean (6734783)
Winston Y. Cheung (6734786)
Guido Giordano (3439904)
George Kim (3385205)
Salah-Eddin Al-Batran (11098)

May 2019

Supplemental material, Supplementary_Table_1 for Real-world comparative effectiveness of nab-paclita...

sj-docx-1-ict-10.1177_15347354211038008 – Supplemental material for Pharmacological Interventions for the Management of Cancer-Related Fatigue Among Cancer Survivors: Systematic Review and Meta-Analysis

Xuemei Sun (811050)
Yancong Chen (4531312)
William KW Cheung (7438010)
Irene XY Wu (7438001)
Fang Xiao (173356)
Vincent CH Chung (7063412)

August 2021

Supplemental material, sj-docx-1-ict-10.1177_15347354211038008 for Pharmacological Interventions for...

sj-docx-3-tam-10.1177_17588359231225038 – Supplemental material for Analysis of circulating tumor DNA identifies distinct therapeutic response to intraperitoneal and intravenous paclitaxel plus S-1 in gastric cancer patients with peritoneal metastasis

Hong Yuan (104486)
Fei Xu (368913)
Shengzhou Wang (9196707)
Di Liu (30843)
Huan Zhang (220065)
Jun Zhang (48506)
Min Shi (141075)
Chao Yan (150844)
Zhenggang Zhu (297842)

January 2024

Supplemental material, sj-docx-3-tam-10.1177_17588359231225038 for Analysis of circulating tumor DNA...

sj-docx-1-opp-10.1177_10781552221126174 - Supplemental material for Economic burden in patients with anaplastic lymphoma kinase (ALK)-positive non-small cell lung cancer (NSCLC), with or without brain metastases, receiving first-line ALK inhibitors

Yanyu Wu (6634754)
Kaili Ren (3845098)
Yin Wan (4164121)
Huamao M Lin (12614506)

September 2022

Supplemental material, sj-docx-1-opp-10.1177_10781552221126174 for Economic burden in patients with ...

sj-docx-1-tam-10.1177_17588359211035983 – Supplemental material for Real-world efficacy and safety of nab-paclitaxel plus gemcitabine-cisplatin in patients with advanced biliary tract cancers: a multicenter retrospective analysis

Abstract

Extracted data

sj-docx-1-tam-10.1177_17588359211035983 – Supplemental material for Real-world efficacy and safety of nab-paclitaxel plus gemcitabine-cisplatin in patients with advanced biliary tract cancers: a multicenter retrospective analysis

Abstract

Extracted data

Related items

Related items